#news #biotech Poxel in €506m diabetes deal with Roivant Sciences

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Poxel in €506m diabetes deal with Roivant Sciences .

from European Biotechnology – first and foremost in European biotech http://ift.tt/2ssr2HJ